OrderlyMeds has announced a telehealth weight loss program that provides patients with compounded GLP-1/GIP, a more affordable alternative to branded medications.
-- Eligible individuals looking for cost-effective alternatives to Zepbound and other brands can enroll in OrderlyMeds’ recently announced weight loss program for prescription compounded semaglutide and tirzepatide. The program combines ongoing clinical support with holistic methods, including guidance on nutrition and physical activity, to promote long-lasting results for patients.
More information is available at https://orderlymeds.com/treatments/glp1s/compounded-glp1-gip/
Glucagon-like peptide-1 receptor agonists, known as GLP-1 drugs, are designed to mimic the GLP-1 hormone. This hormone is released into the gastrointestinal tract in response to food, which in turn stimulates the release of insulin from the pancreas; it also prolongs feelings of fullness and delays the emptying of the stomach. Because these effects reduce appetite, GLP-1 drugs are often prescribed in holistic weight loss programs in combination with other methods.
Common FDA-approved GLP-1 drugs include semaglutides such as Ozempic and Wegovy and tirzepatides such as Zepbound. However, because these medications are branded, they are often more expensive than generic options, especially when used in weight loss programs. To improve accessibility for patients, OrderlyMeds offers tailored compounded GLP-1 and GLP-1/GIP medications as more affordable alternatives to branded options; these are provided as part of its medically supervised telehealth weight loss programs.
Compounded medications are custom-made medications developed to fill a patient’s needs in the event of drug shortages or when indicated by a prescribing practitioner. For OrderlyMeds’ programs, patients are required to complete comprehensive online screening tests to determine eligibility for the medications and help the company’s licensed providers develop the best possible formula for long-term weight loss.
These custom GLP-1/GIP formulations offer a combination of semaglutide and tirzepatide, and they may include supportive additives, like vitamins B6 and B12, to improve digestive comfort, maintain muscle mass, and regulate energy levels.
The company offers two programs: a starter program, which includes 12 weekly doses that gradually increase in increments of 2.5 mg, and a transfer program for individuals who are already on GLP-1s. Regardless of the option, the medications will be delivered to the customer’s doorstep, allowing them to bypass wait times at the pharmacy.
In addition to ongoing medical support from OrderlyMeds’ providers, patients will also be advised on dietary changes, physical activity, mental healthcare, and other aspects of their overall health to promote sustained weight loss.
For more details, visit https://orderlymeds.com/
Contact Info:
Name: Annie Dawson
Email: Send Email
Organization: OrderlyMeds
Address: 235 Ponce De Leon Pl Suite M347, Decatur, Georgia 30030, United States
Website: https://orderlymeds.com/
Source: PressCable
Release ID: 89181219
In the event of encountering any errors, concerns, or inconsistencies within the content shared in this press release, we kindly request that you immediately contact us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your feedback within 8 hours and take appropriate measures to rectify any identified issues or facilitate press release takedowns. Ensuring accuracy and reliability are central to our commitment.
